Merck announced it raked in $60.1 billion in 2023 – an $800 million increase over 2022 – during their earnings report today. While they make billions, Americans pay exorbitantly high prices for prescription drugs. Merck opposed the Biden administration reforms that lower prescription drug prices.
While publicly Merck is claiming price negotiations will hurt the company, during the earnings ...
Please log in to access subscriber content.
If you don't have a subscription, click
here for a WisPolitics free trial and to view the different subscription options.
